Literature DB >> 12825840

Over-the-counter medications in pregnancy.

Ronald A Black1, D Ashley Hill.   

Abstract

Pregnant women commonly use over-the-counter medications. Although most over-the-counter drugs have an excellent safety profile, some have unproven safety or are known to adversely affect the fetus. The safety profile of some medications may change according to the gestational age of the fetus. Because an estimated 10 percent or more of birth defects result from maternal drug exposure, the U.S. Food and Drug Administration has assigned a risk category to each drug. Many drugs have not been evaluated in controlled trials and probably will not be because of ethical considerations. Of the commonly used over-the-counter medications, acetaminophen, chlorpheniramine, kaolin and pectin preparations, and most antacids have a good safety record. Other drugs, such as histamine H2-receptor blockers, pseudoephedrine, and atropine/diphenoxylate should be used with caution. If use of smoking cessation products is desired, the intermediate-release preparations minimize the amount of nicotine while maintaining efficacy. With all over-the-counter medications used during pregnancy, the benefit of the drug should outweigh the risk to the fetus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825840

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  20 in total

1.  Drug exposure and pregnancy outcome in Mozambique.

Authors:  Esperança Sevene; Azucena Bardají; Alda Mariano; Sónia Machevo; Edgar Ayala; Betuel Sigaúque; John J Aponte; Xavier Carné; Pedro L Alonso; Clara Menendez
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Drugs in pregnancy: Implications for a cardiologist.

Authors:  Karel Rakusan
Journal:  Exp Clin Cardiol       Date:  2010

3.  Predictors of the use of medications before and during pregnancy.

Authors:  Marina Odalovic; Sandra Vezmar Kovacevic; Hedvig Nordeng; Katarina Ilic; Ana Sabo; Ljiljana Tasic
Journal:  Int J Clin Pharm       Date:  2013-02-07

4.  Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

Authors:  Marlene Anderka; Allen A Mitchell; Carol Louik; Martha M Werler; Sonia Hernández-Diaz; Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-19

5.  Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.

Authors:  Jennifer N Lind; Sarah C Tinker; Cheryl S Broussard; Jennita Reefhuis; Suzan L Carmichael; Margaret A Honein; Richard S Olney; Samantha E Parker; Martha M Werler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-04-26       Impact factor: 2.890

Review 6.  Pharmacological Management of Insomnia.

Authors:  Sarika Madari; Raphael Golebiowski; Meghna P Mansukhani; Bhanu Prakash Kolla
Journal:  Neurotherapeutics       Date:  2021-02-01       Impact factor: 7.620

7.  Clinical therapeutics in pregnancy.

Authors:  Maisa N Feghali; Donald R Mattison
Journal:  J Biomed Biotechnol       Date:  2011-07-06

Review 8.  Headache in pregnancy: an approach to emergency department evaluation and management.

Authors:  Jessica C Schoen; Ronna L Campbell; Annie T Sadosty
Journal:  West J Emerg Med       Date:  2015-02-25

Review 9.  Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.

Authors:  Helmut H Albrecht; Peter V Dicpinigaitis; Eric P Guenin
Journal:  Multidiscip Respir Med       Date:  2017-12-11

10.  Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences.

Authors:  Afshan Dean; Sander van den Driesche; Yili Wang; Chris McKinnell; Sheila Macpherson; Sharon L Eddie; Hazel Kinnell; Pablo Hurtado-Gonzalez; Tom J Chambers; Kerrie Stevenson; Elke Wolfinger; Lenka Hrabalkova; Ana Calarrao; Rosey Al Bayne; Casper P Hagen; Rod T Mitchell; Richard A Anderson; Richard M Sharpe
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.